Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable By: MarketWatch October 20, 2023 at 07:10 AM EDT Once buoyed by demand for COVID-19 vaccines and treatments, the biotech industry is experiencing a sobering leveling out Read More >> Related Stocks: BioNTech SE - American Depositary Shares Moderna, Inc. - Common Stock Novavax, Inc. - Common Stock Pfizer
